Company Overview of Prolong Pharmaceuticals, LLC
Prolong Pharmaceuticals, LLC, a biopharmaceutical company, develops products for the treatment of anemia resulting from oxygen deficiency and hemolysis. It offers SANGUINATE, an investigational bio-pharmaceutical product that facilitates the transfer of oxygen to oxygen-deprived cells and tissues and down-regulates the inflammatory response in blood samples of sickle cell disease (SCD) patients. The company’s products also include ANF-Rho to create a novel molecule with a unique mechanism of action; EPEG, a long-acting 3rd generation PEGylated EPO biologic for the treatment of anemia; and PP-403, a novel cytokine with applications in cancer; and hematology products. Prolong Pharmaceuticals, ...
1 Cragwood Road
South Plainfield, NJ 07080
Founded in 2002
Key Executives for Prolong Pharmaceuticals, LLC
Founder, Chief Executive Officer, Chief Scientific Officer and Director
Vice President of Information Services
Vice President of Quality
Compensation as of Fiscal Year 2015.
Prolong Pharmaceuticals, LLC Key Developments
Prolong Pharmaceuticals, LLC Presents at Boston Biotech Conferences 2015, Nov-12-2015 01:30 PM
Sep 22 15
Prolong Pharmaceuticals, LLC Presents at Boston Biotech Conferences 2015, Nov-12-2015 01:30 PM. Venue: Apella, 450 East 29th Street, NY 10016, New York, United States. Speakers: Glenn Kazo, President.
Prolong Pharmaceuticals, Inc. Presents at The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum, Mar-19-2014 04:15 PM
Mar 12 14
Prolong Pharmaceuticals, Inc. Presents at The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum, Mar-19-2014 04:15 PM. Venue: New York Academy of Sciences, New York, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries